Revance therapeutics shareholder alert: claimsfiler reminds investors with losses in excess of $100,000 of lead plaintiff deadline in class action lawsuit against revance therapeutics, inc. - rvnc

New orleans, jan. 12, 2022 /prnewswire/ -- claimsfiler, a free shareholder information service, reminds investors that they have until february 8, 2022 to file lead plaintiff applications in a securities class action lawsuit against revance therapeutics, inc. (nasdaqgm: rvnc), if they purchased the company's shares between november 25, 2019 and october 11, 2021, inclusive (the "class period").  this action is pending in the united states district court for the northern district of california.
RVNC Ratings Summary
RVNC Quant Ranking